Clinical trials: Cardiovascular Death
Multiple Myeloma, Myelodysplastic Syndromes
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
Patients diagnosed with hematologic cancer are at substantial risk of dying, as 5-year survival among patients with acute myeloid leukemia is 20 % and only every second patient treated for incurable myeloma lives 5 years after…
- Conditions
- Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Acute Myeloid Leukemia
- Trial name
- ACT (NCT05444348)
- Testing
- Advance consultation concerning your life and treatment (ACT )
- Where
- 7 sites in Denmark
- Volunteers
- 920 people
- Sponsor
- Christoffer Johansen